Furey Raymond J. 4
4 · RIGEL PHARMACEUTICALS INC · Filed Jan 31, 2025
Insider Transaction Report
Form 4
Furey Raymond J.
EVP, GC, CCO & Corp Sec
Transactions
- Award
Common Stock
2025-01-29+19,717→ 41,617 total - Award
Employee Stock Option (Right to Buy)
2025-01-29+14,788→ 14,788 totalExercise: $22.49Exp: 2035-01-29→ Common Stock (14,788 underlying)
Footnotes (4)
- [F1]The shares of common stock are to be acquired upon the vesting of a Restricted Stock Unit award granted to the Reporting Person. The Restricted Stock Units shall vest annually over three (3) years from February 10, 2025, with the first annual vest occurring on February 10, 2026.
- [F2]This number has been adjusted to reflect the one-for-ten reverse stock split effective June 27, 2024.
- [F3]Includes 500 shares acquired under the Issuer's stock purchase plan.
- [F4]The shares of common stock subject to the option vest monthly over three (3) years from the vesting commencement date of January 29, 2025, subject to the Reporting Person's continuous service to the Issuer through each such period.